Phase 2 Antiphospholipid Syndrome Clinical Trials
7 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–7 of 7 trials
Recruiting
Phase 2
Anifrolumab in Adults With Primary Antiphospholipid Syndrome (AnifAPS Trial)
Antiphospholipid Syndrome (APS)
National and Kapodistrian University of Athens20 enrolled1 locationNCT07584083
Recruiting
Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Pregnancy ComplicationsHigh Risk PregnancyAntiphospholipid Syndrome in Pregnancy+1 more
David Ware Branch55 enrolled3 locationsNCT03152058
Recruiting
Phase 1Phase 2
Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases
Sjogren SyndromeSystemic Lupus ErthematosusSystemic Sclerosis (SSc)+3 more
Peking University Third Hospital9 enrolled1 locationNCT06828042
Recruiting
Phase 2
Anti-CD38 Antibody Treating APS With Thrombocytopenia
ThrombocytopeniaAntiphospholipid Syndrome
Institute of Hematology & Blood Diseases Hospital, China10 enrolled1 locationNCT05983952
Recruiting
Phase 2
BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases
Systemic Lupus ErythematosusSjogren SyndromeInflammatory Myopathy+6 more
Peking University People's Hospital50 enrolled1 locationNCT06794008
Recruiting
Phase 2
Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia
TreatmentThrombocytopeniaAntiphospholipid Syndrome
Institute of Hematology & Blood Diseases Hospital, China10 enrolled2 locationsNCT05199909
Recruiting
Phase 2
Effect of Belimumab on Antibody Titers in Primary APS Patients
Antiphospholipid Syndrome (APS)
Ruijin Hospital20 enrolled1 locationNCT06747312